Nauka i natura

The outbreak of a novel coronavirus (SARS-CoV-2) has been a global concern that spurs an urgent need for antiviral drug discovery. With years of experience in antiviral drug development, Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in drug candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration. Our high-throughput screening (HTS) technology can rapidly identify promising antiviral agents against SARS-CoV-2 infection from large libraries of approved drugs and pharmacologically active compounds, inhibitors, proteins, antibodies and peptides. sars High-Throughput Screening
https://sars-cov-2.creative-biolabs.com/high-throughput-screening-hts-services-of-sars-cov-2-drug-candidates.htm